Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down – Time to Sell?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $341.00, but opened at $310.00. Bio-Rad Laboratories shares last traded at $310.00, with a volume of 104 shares.

Bio-Rad Laboratories Stock Performance

The stock has a market cap of $9.77 billion, a PE ratio of -12.77 and a beta of 0.72. The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16. The firm has a fifty day simple moving average of $334.05 and a two-hundred day simple moving average of $326.52.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its earnings results on Wednesday, October 30th. The company reported $2.01 earnings per share (EPS) for the quarter. The business had revenue of $649.73 million during the quarter. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.